Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,491 | -3,223 | -24,481 | -19,773 | -17,923 |
| Depreciation Amortization | 1,584 | 1,584 | 8,019 | 2,021 | N/A |
| Other Working Capital | -1,047 | -1,408 | 533 | -348 | -667 |
| Other Operating Activity | -1,201 | 9 | 11,005 | 14,105 | 15,698 |
| Operating Cash Flow | $-5,154 | $-3,039 | $-4,924 | $-3,996 | $-2,892 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,000 | 2,000 | 10,300 | 9,817 | 3,050 |
| Debt Repayment | -2,174 | -2,174 | -3,033 | -3,033 | N/A |
| Other Financing Activity | 16,491 | 8,066 | -1,344 | -844 | 44 |
| Financing Cash Flow | $16,317 | $7,892 | $5,924 | $5,940 | $3,094 |
| Beginning Cash Position | 1,004 | 1,004 | 4 | 4 | 4 |
| End Cash Position | 12,167 | 5,857 | 1,004 | 1,948 | 206 |
| Net Cash Flow | $11,163 | $4,853 | $1,000 | $1,945 | $203 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,154 | -3,039 | -4,924 | -3,996 | -2,892 |
| Free Cash Flow | -5,154 | -3,039 | -4,924 | -3,996 | -2,892 |